Prevention of preeclampsia
- PMID: 27841760
- PMCID: PMC5127661
- DOI: 10.1172/JCI91300
Prevention of preeclampsia
Abstract
Preeclampsia is a common complication of pregnancy that is associated with an increased risk of maternal and neonatal morbidity and mortality. Currently, delivery is the only cure for preeclampsia; therefore, effective prevention and treatment options for this condition are sorely needed. In the current issue of the JCI, Mirzakhani et al. report the findings of the Vitamin D Antenatal Asthma Reduction Trial (VDAART), a well-conducted large, randomized, double-blind, placebo-controlled trial of vitamin D supplementation for the prevention of preeclampsia. Though vitamin D supplementation had no effect on the risk of preeclampsia, reduced maternal serum vitamin D levels did correlate with preeclampsia risk. Mirzakhani and colleagues identified a number of gene pathways that are differentially regulated among women with low serum vitamin D levels who develop preeclampsia. These results indicate that further research on the role of vitamin D in preeclampsia is warranted.
Conflict of interest statement
The author has declared that no conflict of interest exists.
Comment on
-
Early pregnancy vitamin D status and risk of preeclampsia.J Clin Invest. 2016 Dec 1;126(12):4702-4715. doi: 10.1172/JCI89031. Epub 2016 Nov 14. J Clin Invest. 2016. PMID: 27841759 Free PMC article. Clinical Trial.
References
-
- HCUP Statistical Briefs Chronological. Healthcare Cost and Utilization Project (HCUP). Agency for Healthcare Research and Quality, Rockville, Maryland USA. HCUP Web site. www.hcup-us.ahrq.gov/reports/statbriefs/statbriefs.jsp Accessed October 19, 2016.
-
- American College of Obstetricians Gynecologists Task Force on Hypertension Pregnancy. Hypertension In Pregnancy. Washington, DC, USA: ACOG; 2013. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical